Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

N/ACompletedNCT06819527

Jordan University of Science and Technology323 enrolled

Overview

This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

323

Conditions

Chronic Kidney Disease(CKD)

Interventions

Medication reconciliation serviceOTHER

Patients in the interventional group received medication reconciliation at admission and discharge in addition to continuous medication review during their admissions.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours. Exclusion Criteria: * Patients with kidney transplantation . * Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave. * Patients who refused to provide a written informed consent.

Locations (1)

King Abdullah University Hospital and Princess Basma Hospital

Irbid, Jordan

Outcomes

Primary Outcomes

all-cause 90-day readmission

The primary outcome in this study was the likelihood of all-cause 90-day readmission as extracted from medical records for both study groups

Time frame: 90 days after discharge

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.